Best Practices in Adopting Single-Use Systems
Key considerations for implementing single-use components or platforms when moving from research to process development.
Drugs, At What Cost?
Generics, market dynamics, and global demand are changing drug spending patterns.
2014 Manufacturing Trends and Outlook
Single-use systems and other technologies drive process efficiencies, but there is room for improvement.
Early Communication with Regulators is Essential for SMEs
With SMEs gaining wider recognition as the powerhouse of research and innovation in Europe, regulatory agencies are urging companies to engage with regulators early in the drug-development process.
Downstream Purification and Formulation of Fab Antibody Fragments
Antibody fragments pose unique challenges in recovery, purification, and formulation.
Life-Sciences IPOs Take a Breather
Frenzy cools as investors seeking a quick return turn elsewhere.
Innovation and Market Growth in Brazil
Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator.
Progress in the Prediction of Protein Aggregation
Techniques to enable the design and formulation of stable, protein-based therapeutics.
Metrics Sought to Ensure Drug Quality
Regulators work with manufacturers to improve systems for measuring product performance and manufacturing reliability.
Determining Criticality—Process Parameters and Quality Attributes Part II: Design of Experiments and Data-Driven Criticality
Criticality is used as a risk-based tool to drive control strategies.
R&D in Transition
The R&D model is in transition and creating new demands on contract services providers.
BioPharm International, January 2014 Issue (PDF)
Click the title above to open the BioPharm International January 2014 issue in an interactive PDF format.
